In addition, studies have found that STAT5 expression is associated with increased overall survival and better response to endocrine therapy in estrogen receptor (ER)-positive breast cancer, and that activated STAT5 is associated with better breast cancer-specific and disease-free survival in lymph node-negative breast cancer [22,23]. The gene discussed is ESR1; the disease is breast carcinoma.